Abstract:Background: This study aims to explore the variations of hepatic vascular geometries in patients with clinically significant portal hypertension (CSPH) and investigate the capability of using CT/MRI angiographic imaging-based vascular geometrical model (VGM) to identify CSPH patients. Methods: A total of 64 vascular geometrical parameters were extracted from the portal vein (PV), hepatic vein (HV), aorta and inferior vena cava and then fed into a VGM for identification of CSPH patients. A total of 853 consecutive liver cirrhosis patients from 3 medical centers who underwent contrast-enhanced imaging within 14 days of transjugular catheterization for hepatic venous pressure gradient (HVPG) were included. The VGM model was trained and validated on a CT cohort containing 256 cirrhosis patients and 202 age-matched participants without a history of chronic liver diseases, and tested on both CT and MR cohorts. Findings: Significant reduction of whole vessel volumes were observed in both PV (from 36·90±15·99 to 29·61±11·07 cm3) and HV (from 35·28±21·47 to 22·44±15·65 cm3) when CSPH occurred. Similarly, whole vessel lengths were reduced in CSPH patients in both PV (from 3·00±2·37 to 1·72±1·23 m) and HV (from 1·83±1·48 to 0·91±1·51 m). The number of external associations of vessel parameters (defined as R>0·5) increased when CSPH occurred, which verified the derangement of the vascular system in the liver. The performance of VGM outperformed conventional clinical models significantly in both internal and external validation cohorts. Interpretation: This study developed and validated a contrast-enhanced CT/MRI-based VGM with good diagnostic consistency to the HVPG measurement, which shows good potential for clinical applications.Trial Registration: We conducted this study using the database of a CT cohort (CHESS1701; ClinicalTrials.gov identifier: NCT03138915) between August 2016 and September 2017 and a MR cohort (CHESS1802; ClinicalTrials.gov identifier: NCT03766880) from December 2018 toApril 2019.Funding: This study was funded by the National Natural Science Foundation of China (No. 81971583, No. 62001120), National Key R&D Program of China (No. 2018YFC1312900, No. 2019YFA0709502), Science Fund for Distinguished Young Scholars (No. 20JR10RA713), Shanghai Natural Science Foundation (No. 20ZR1406400), Shanghai Municipal Science and Technology Major Project (No.2017SHZDZX01, No.2018SHZDZX01), Shanghai Municipal Science and Technology (No.17411953600), Shanghai Sailing Program (No. 20YF1402400), ZJLab and Key Laboratory of Computational Neuroscience and BrainInspired Intelligence (Fudan University), Ministry of Education, China.Declaration of Interest: The authors declare no conflict of interest.Ethical Approval: The study was in agreement with the ethical guidelines of the 1975 Declaration ofHelsinki and approved by the Ethics Committee of the Fifth Medical Center at PLAGeneral Hospital. The requirement for informed consent was waived.

MRI-based Liver Vascular Morphology and Surface Nodularity Quantification for Assessment of Portal Hypertension

[Value of 3D-DCE MRA in Diagnosis of Cavernous Transformation of Portal Vein].

Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model

Non-invasive Assessment of Hepatic Venous Pressure Gradient (HVPG) Based on MR Flow Imaging and Computational Fluid Dynamics

Four-dimensional Flow Magnetic Resonance Imaging for Noninvasive Diagnosis of Clinically Significant Portal Hypertension and High-Risk Gastroesophageal Varices in Patients with Cirrhosis

Magnetic Resonance Elastography and Portal Hypertension: Influence of the Portal Venous Flow on the Liver Stiffness

Application of portal vein pressure measurement based on computational fluid dynamics in preoperative planning of resection of hepatic carcinoma

Development and Validation of a Hepatic Vascular Geometrical Model for Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)

Non-invasive predictive model for hepatic venous pressure gradient based on a 3-dimensional computed tomography volume rendering technology

Prediction model of portal pressure for HBV-related cirrhosis based on radiomics feature

The Early Diagnostic Value of MRI in Liver Cirrhosis and Portal Hypertension

Noncontrast-enhanced MRI-based Noninvasive Score for Portal Hypertension (CHESS1802): an International Multicenter Study

Contrast‐Enhanced Sonography for Quantitative Assessment of Portal Hypertension in Patients with Liver Cirrhosis

4D Flow MRI of Portal Vein Hemodynamics in Healthy Volunteers and Patients with Chronic Liver Disease.

An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension

Flow Resistance Analysis of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis.

Application of CT-based radiomics in predicting portal pressure and patient outcome in portal hypertension.

Invasive and Non-invasive Diagnosis of Portal Hypertension in Cirrhosis

Bibliometric-analysis visualization and review of non-invasive methods for monitoring and managing the portal hypertension

[Clinical Value of Contrast-Enhanced Ultrasound in Evaluating Portal Hypertension in Patients with Decompensated Liver Cirrhosis].

Computed tomography perfusion in differentiating portal hypertension: A correlation study with hepatic venous pressure gradient